Curis, Inc. Named One Of New England's Fastest Growing Life Sciences Companies In Deloitte's Technology Fast 50 Program

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 14, 2006--Curis, Inc., (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, has been named to Deloitte's prestigious Technology Fast 50 Program for New England, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area by Deloitte & Touche USA LLP, one of the nation's leading professional services organizations. Rankings are based on the percentage revenue growth over five years from 2001-2005.